Speciality: All Speciality
Description:
A warm welcome to all the medical professionals in this interesting session on The game changing DTP Combination Vaccine evolution to improve VCR.
The DTP (Diphtheria, Tetanus, and Pertussis) combination vaccine has been a cornerstone of childhood immunization programs worldwide. Its evolution marks significant advancements in improving vaccine coverage rates (VCR), ensuring broader protection against these serious infectious diseases.
Over the years, the DTP vaccine has undergone several modifications to enhance its efficacy and safety. Initially, whole-cell pertussis vaccines were used, which, although effective, were associated with higher rates of adverse reactions. The development of acellular pertussis vaccines (DTaP) offered a safer alternative with fewer side effects, leading to increased acceptance and higher vaccination rates.
Research is being conducted to develop next-generation vaccines that offer even broader protection with fewer doses. Additionally, efforts to educate communities and address vaccine hesitancy are essential to further improve VCR and sustain the gains achieved in controlling these preventable diseases.
Therefore, get an overall knowledge of the game changing DTP combination vaccine evolution to improve VCR.
See More Webinars @ Hidoc Webinars
1.
Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity
2.
Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
5.
Microplastics can cause malignant changes in lung cells
1.
Exploring the Potential of Cytologic Atypia in Cancer Diagnosis
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
AI-Powered Rehabilitation: A Game Changer for Hemophilia Management
4.
Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success
5.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Navigating the Complexities of Ph Negative ALL - Part I
5.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation